NCT02497898View on ClinicalTrials.gov

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2038

Study Completion Date

July 31, 2040

Conditions
Lymphoma, Non-Hodgkin
Interventions
BIOLOGICAL

Cytokine-induced killer cells (CIK)

Cytokine-induced killer (CIK) cells are able to eradicate lymphomas and other malignancies. CIK cells are generated by incubation of peripheral blood lymphocytes with an anti-cluster of differentiation 3 (anti-CD3) monoclonal antibody, interleukin-2 (IL-2), interleukin-1 (IL-1) and interferon-gamma.

All Listed Sponsors
lead

The First People's Hospital of Changzhou

OTHER